Biotech News
Related news
PolyPid
Local Controlled-Release Therapeutics PolyPid develops long-acting medicines that release active drugs directly at a surgical or disease site. This approach is intended to improve local exposure while limiting systemic treatment burden. PLEX Technology The PLEX platform embeds drugs within a biodegradable polymer-lipid matrix to control...
Recent company news
PYPDPolyPid2026-11-11 12:30 EST
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
PYPDPolyPid2026-10-29 12:00 EST
PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
PYPDPolyPid2026-10-28 12:00 EST
PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections
PYPDPolyPid2026-10-21 12:00 EST
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
PYPDPolyPid2026-10-15 12:30 EST
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
Stock data
- Close
- 6.55 USD
- Market cap
- 93.38M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
